-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DoZU20KN4ZkHsH2IkqX9RvRLzUMRLAANQ2ax2RuoaXvqxcEt7VbgyuL5vwo5UrGR PN+oqsEUqPcOU2HFwjdwcA== 0001127563-03-000224.txt : 20031014 0001127563-03-000224.hdr.sgml : 20031013 20031014114709 ACCESSION NUMBER: 0001127563-03-000224 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20031014 EFFECTIVENESS DATE: 20031014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CDC NVEST FUNDS TRUST I CENTRAL INDEX KEY: 0000770540 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 811-04323 FILM NUMBER: 03938591 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON ST CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 8002831155 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: NVEST FUNDS TRUST I DATE OF NAME CHANGE: 20000202 FORMER COMPANY: FORMER CONFORMED NAME: NEW ENGLAND FUNDS TRUST I DATE OF NAME CHANGE: 19940614 FORMER COMPANY: FORMER CONFORMED NAME: NEW ENGLAND FUNDS DATE OF NAME CHANGE: 19920703 DEFA14A 1 defa14a1013.txt FACING SHEET SECOND SOLICITATION LETTER SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) Filed by the registrant [X] Filed by a party other than the registrant [ ] Check the appropriate box: [ ] Preliminary proxy statement. [ ] Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) [ ] Definitive proxy statement. [ ] Definitive additional materials. [X] Soliciting material under rule 14a-12 CDC Nvest Funds Trust I - -------------------------------------------------------------------------------- (Name of Registrant as Specified in Its Charter) - -------------------------------------------------------------------------------- (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of filing fee (check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: - -------------------------------------------------------------------------------- (2) Aggregate number of securities to which transaction applies: - -------------------------------------------------------------------------------- (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): - -------------------------------------------------------------------------------- (4) Proposed maximum aggregate value of transaction: - -------------------------------------------------------------------------------- (5) Total fee paid: - -------------------------------------------------------------------------------- [ ] Fee paid previously with preliminary materials. - -------------------------------------------------------------------------------- [ ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount previously paid: - -------------------------------------------------------------------------------- (2) Form, Schedule or Registration Statement No.: - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- (3) Filing Party: (4) Date Filed: - -------------------------------------------------------------------------------- [CDC NVEST FUNDS LETTERHEAD] October 13, 2003 Our records as of October 10, 2003 indicate that we have not received your proxy vote. We want you to know that your vote matters! Dear Shareholder: We recently sent you a package containing a prospectus/proxy statement that provided detailed information regarding an important proposal affecting your CDC Nvest Fund. Our records indicate that you have not yet responded. Your vote is important. Please take some time to review the document and vote your shares today. If your vote and this letter have crossed in the mail, we thank you for your response. PLEASE RESPOND BY NOVEMBER 7, 2003! Your vote is needed prior to the shareholder meeting, which is scheduled for November 11, 2003 at 2:00 p.m. Eastern time at the offices of CDC IXIS Asset Management Advisers, L.P. at 399 Boylston Street, 10th Floor, Boston, Massachusetts 02116. There are three convenient methods for voting your shares: X Visit www.cdcnvestfunds.com to vote electronically by Internet, where you will also find copies of the proxy letter, a set of Q&As, and the proxy statement. X Call toll-free 866-241-6192 to vote on our automated telephone line. X Return the enclosed proxy card in the postage-paid envelope provided. If you plan to vote electronically by Internet or by telephone, please see your proxy card for more information and helpful instructions. You may also receive a telephone call from a proxy solicitation firm to remind you to vote your shares. Thank you for your cooperation in voting on this important proposal. If you have any questions, please call 800-225-5478. One of our representatives will be happy to provide you with the information you need. Sincerely, /s/ John T. Hailer John T. Hailer President CDC IXIS Asset Management Distributors, L.P. o 399 Boylston Street o Boston, Massachusetts 02116 www.cdcnvestfunds.com LCG05-1003 -----END PRIVACY-ENHANCED MESSAGE-----